Home > Healthcare > Medical Devices > Implantable Devices > Hydrocephalus Shunt Market

Hydrocephalus Shunt Market Share

Report ID: GMI9350
Published Date: May 2024
Report Format: PDF

Download Free Sample

Hydrocephalus Shunt Market Share

The hydrocephalus shunt industry is highly fragmented due to the presence of large number of established vendors and new entrants. Advancements in materials science, miniaturization, and manufacturing processes have made it more viable for smaller companies to develop and produce hydrocephalus shunt devices. Established vendors are adopting collaborations and partnership as a key strategy to gain competitive edge in the market. Small scale vendors are relying towards offering low-cost products to compete with established players in the market.

Hydrocephalus Shunt Market Companies

Prominent players operating in the hydrocephalus shunt industry include:

B. Braun Melsungen AG
CHRISTOPH MIETHKE GMBH & CO. KG
DESU MED?KAL A.?.
G. Surgiwear Ltd.
Hpbio
Integra LifeSciences Corporation
Kaneka Medix Corp.
Luciole Medical AG
Medtronic plc
Natus Medical Incorporated
SOPHYSA
TKB Corporation

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global hydrocephalus shunt market size was valued at USD 460.5 million in 2023 and is anticipated to showcase 3.5% CAGR from 2024

The ventriculoperitoneal segment in the market generated USD 401.6 million in 2023, due to their higher reliability specifically during the treatment of congenital hydrocephalus.

North America hydrocephalus shunt market held 40.2% revenue share in 2023 and is predicted to reach USD 238.7 million by 2032, driven by growing awareness towards hydrocephalus shunting procedures through awareness campaigns.

B. Braun Melsungen AG, CHRISTOPH MIETHKE GMBH & CO. KG, DESU MED?KAL A.?., G. Surgiwear Ltd., Hpbio, Integra LifeSciences Corporation, Kaneka Medix Corp., Luciole Medical AG, Medtronic plc, Natus Medical Incorporated, SOPHYSY and TKB Corporation